Expression of matrix metalloproteinases during experimental Candida albicans keratitis

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 2, 2009, Pages 737-742

  Yuan, Xiaoyong ^a   Mitchell, Bradley M ^a   Wilhelmus, Kirk R ^a  

^a CULLEN EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE 3; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MACROPHAGE ELASTASE; MATRILYSIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 15; MATRIX METALLOPROTEINASE 16; MATRIX METALLOPROTEINASE 17; MATRIX METALLOPROTEINASE 19; MATRIX METALLOPROTEINASE 20; MATRIX METALLOPROTEINASE 23; MATRIX METALLOPROTEINASE 24; NEUTROPHIL COLLAGENASE; STROMELYSIN; STROMELYSIN 2; STROMELYSIN 3; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TISSUE INHIBITOR OF METALLOPROTEINASE 4; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CONTROLLED STUDY; CORNEA EPITHELIUM; CORNEA STROMA; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FUNGAL STRAIN; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; KERATOMYCOSIS; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; CORNEA ULCER; DISEASE MODEL; DNA MICROARRAY; FLUORESCENT ANTIBODY TECHNIQUE; FUNGAL EYE INFECTION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MICROBIOLOGY; PHYSIOLOGY;

ANIMALS; CANDIDIASIS; CORNEAL ULCER; DISEASE MODELS, ANIMAL; EYE INFECTIONS, FUNGAL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED BALB C; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TISSUE INHIBITOR OF METALLOPROTEINASES; UP-REGULATION;

EID: 59449094495     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-2390     Document Type: Article

References (30)

1. Leck AK, Thomas PA, Hagan M, et al. Aetiology of suppurative corneal ulcers in Ghana and south India, and epidemiology of fungal keratitis. Br J Ophthalmol. 2002;86:1211-1215.
2. Kercher L, Wardwell SA, Wilhelmus KR, Mitchell BM. Molecular screening of donor corneas for fungi before excision. Invest Ophthalmol Vis Sci. 2001;42:2578-2583.
3. Wu T, Mitchell BM, Carothers T, et al. Molecular analysis of the pediatric ocular surface for fungi. Curr Eye Res. 2003;2003:33-36.
4. Sun RL, Jones DB, Wilhelmus KR. Clinical characteristics and outcome of Candida keratitis. Am J Ophthalmol. 2007;143:1043-1045.
5. O'Day DM, Head WS, Csank C, et al. Differences in virulence between two Candida albicans strains in experimental keratitis. Invest Ophthalmol Vis Sci. 2000;41:1116-1121.
6. Wu TG, Wilhelmus KR, Mitchell BM. Experimental keratomycosis in a mouse model. Invest Ophthalmol Vis Sci. 2003;44:210-216.
7. Jackson BE, Wilhelmus KR, Mitchell BM. Genetically regulated filamentation contributes to Candida albicans virulence during corneal infection. Microb Pathog. 2007;42:88 -93.
8. Malemud CJ. Matrix metalloproteinases (MMPs) in health and disease: an overview. Front Biosc. 2006;11:1696-1701.
9. Sivak JM, Fini ME. MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology. Prog Retin Eye Dis. 2002; 21:1-14.
10. Ma JJ, Dohlman CH. Mechanisms of corneal ulceration. Ophthalmol Clin North Am. 2002;15:27-33.
11. Yang YN, Bauer D, Wasmuth S, Steuhl KP, Heiligenhaus A. Matrix metalloproteinases (MMP-2 and 9) and tissue inhibitors of matrix metalloproteinases (TIMP-1 and 2) during the course of experimental necrotizing herpetic keratitis. Exp Eye Res. 2003;77:227-237.
12. McClellan SA, Huang X, Barrett RP, et al. Matrix metalloproteinase-9 amplifies the immune response to Pseudomonas aeruginosa corneal infection. Invest Ophthalmol Vis Sci. 2006;47:256-264.
13. Carter RT, Kambampati R, Murphy CJ, Bentley E. Expression of matrix metalloproteinase 2 and 9 in experimentally wounded canine corneas and spontaneous chronic corneal epithelial defects. Cornea. 2007;26:1213-1219.
14. Ikema K, Matsumoto K, Inomata Y, et al. Induction of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs correlates with outcome of acute experimental pseudomonal keratitis. Exp Eye Res. 2006;83:1396-1404.
15. Xue ML, Wakefield D, Willcox MD, et al. Regulation of MMPs and TIMPs by IL-1beta during corneal ulceration and infection. Invest Ophthalmol Vis Sci. 2003;44:2020-2025.
16. Kernacki KA, Chunta JL, Barrett RP, Hazlett LD. TIMP-1 role in protection against Pseudomonas aeruginosa-induced corneal destruction. Exp Eye Res. 2004;78:1155-1162.
17. Dong X, Shi W, Zeng Q, Xie L. Roles of adherence and matrix metalloproteinases in growth patterns of fungal pathogens in cornea. Curr Eye Res. 2005;30:613-620.
18. Rohini G, Murugeswari P, Prajna NV, Lalitha P, Muthukkaruppan V. Matrix metalloproteinases (MMP-8, MMP-9) and the tissue inhibitors of metalloproteinases (TIMP-1, TIMP-2) in patients with fungal keratitis. Cornea. 2007;26:207-211.
19. Mitchell BM, Wu TG, Chong EM, Pate JC, Wilhelmus KR. Expression of matrix metalloproteinases 2 and 9 in experimental corneal injury and fungal keratitis. Cornea. 2007;26:589-593.
20. Zhai HL, Xie LX, Dong XG. The role of gelatinases in pathological changes of fungal keratitis in experimental rabbits. Zhonghua Yan Ke Za Zhi. 2007;43:817-822.
21. Mitchell BM, Wu TG, Jackson BE, Wilhelmus KR. Candida albicans strain-dependent virulence and Rim13p-mediated filamentation in experimental keratomycosis. Invest Ophthalmol Vis Sci. 2007;48:774-780.
22. Wong TT, Sethi C, Daniels JT, Limb GA, Murphy G, Khaw PT. Matrix metalloproteinases in disease and repair processes in the anterior segment. Surv Ophthalmol. 2002;47:239-256.
23. Ollivier FJ, Gilger BC, Barrie KP, et al. Proteinases of the cornea and preocular tear film. Vet Ophthalmol. 2007;10:199-206.
24. Lee S, Zheng M, Kim B, Rouse BT. Role of matrix metalloproteinase-9 in angiogenesis caused by ocular infection with herpes simplex virus. J Clin Invest. 2002;110:1105-1111.
25. Azkur AK, Kim B, Suvas S, Lee Y, Kumaraguru U, Rouse BT. Blocking mouse MMP-9 production in tumor cells and mouse cornea by short hairpin (sh) RNA encoding plasmids. Oligonucleotides. 2005;15:72-84.
26. Ye HQ, Maeda M, Yu FSX, Azar DT. Differential expression of MT1-MMP (MMP-14) and collagenase III (MMP-13) genes in normal and wounded rat corneas. Invest Ophthalmol Vis Sci. 2000;41: 2894-2899.
27. Li D-Q, Shang TY, Kim HS, Solomon A, Lokeshwar BL, Pflugfelder SC. Regulated expression of collagenases MMP-1, -8, and -13 and stromelysines MMP-3, -10, and -11 by human corneal epithelial cells. Invest Ophthalmol Vis Sci. 2003;44:2928-2936.
28. Lee MM, Yoon BJ, Osiewicz K, et al. Tissue inhibitor of metalloproteinase 1 regulates resistance to infection. Infect Immun. 2005; 73:661-665.
29. Jackson BE, Mitchell BM, Wilhelmus KR. Corneal virulence of Candida albicans strains deficient in Tup1-regulated genes. Invest Ophthalmol Vis Sci. 2007;48:2535-2539.
30. Claveau I, Mostefaoui Y, Rouabhia M. Basement membrane protein and matrix metalloproteinase deregulation in engineered human oral mucosa following infection with Candida albicans. Matrix Biol. 2004;23:477-486.